CN Patent

CN1561201A — 包含胶态二氧化硅的药物组合物

Assigned to Novartis AG · Expires 2005-01-05 · 21y expired

What this patent protects

本发明涉及包含大环内酯固体分散体、崩解剂和胶态二氧化硅的药物组合物，其中组合物包含以重量计1％至5％的胶态二氧化硅。

USPTO Abstract

本发明涉及包含大环内酯固体分散体、崩解剂和胶态二氧化硅的药物组合物，其中组合物包含以重量计1％至5％的胶态二氧化硅。

Drugs covered by this patent

Risperdal (risperidone) · Johnson & Johnson (Janssen)

Patent Metadata

Patent number: CN1561201A
Jurisdiction: CN
Classification: —
Expires: 2005-01-05
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.